Where does Superlab FAR East Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Superlab FAR East Limited ranks #43,401 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Superlab FAR East Limited hold?

Superlab FAR East Limited holds 6 US utility patents granted between 2016 and 2024, spanning 10 technology areas.

What is Superlab FAR East Limited's Innovation Score?

Superlab FAR East Limited has an Innovation Score of 27.4 out of 100 (24th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Superlab FAR East Limited's patent grant rate increasing or decreasing?

Superlab FAR East Limited's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Superlab FAR East Limited's patents?

Superlab FAR East Limited's patents average 12.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Superlab FAR East Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Superlab FAR East Limited

Q: What technology areas does Superlab FAR East Limited focus on?

Superlab FAR East Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 6 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 10 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Superlab ranks #43,401 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 10 technology areas.

#43,401
of 49,997 US assignees by volume: 24th percentile
by Innovation Score (27.4/100): 12.2
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R43401 · Foreign Corporation #43,401 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #43,401/49,997
PHOTO-FINISH Sung Jung Minute…
CPC-FOCUS A61P · 10 areas
INNOV-THIN 27.4/100
CLAIMS-RICH 12.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sung Jung Minute Industry Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Superlab FAR East · this assignee

27
3D Lighting… · lowest

7

What this shows Superlab's Innovation Score is 27.4/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Superlab's grants concentrate

Superlab FAR East Limited is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Superlab sits between Sung Jung Minute Industry Co., Ltd. and Suss Microtec Photonic Systems Inc..

Superlab's three-year grant acceleration

Superlab FAR East Limited shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sung Jung Minute…

6
Sunia PTE

6
Sunpine AB

6
Sunsight Holdings

6
Suprema HQ

6
Surgisense

6
Suspension Systems

6
Suss Microtec Pho…

6
Superlab FAR East ◀

6

What this shows Superlab holds 6 patents at rank #43,037, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Superlab

By rank, the assignees closest to #43,037 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Superlab's primary technology class.

Superlab's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 24th percentile higher than 24% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Superlab FAR East Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	16.7%
2018	1	16.7%
2020	3	50.0%
2024	1	16.7%

Which technologies does Superlab FAR East Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07K - Peptides 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#43,401

of 49,997 tracked assignees

Innovation Score

27.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Superlab FAR East Limited's patent record in context - here's where to go next.

Superlab FAR East Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #43,401 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Superlab FAR East Limited against Sung Jung Minute Industry Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.